Shah Gaurav (CIK 0001725922)

Latest company ownership

Shares held
406,238
Last filed at
Nov 20, 2025
Confidence Score
41.7
2025Q4
Confidence Score History
2019Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 18, 2025 Nov 20, 2025 ROCKET PHARMACEUTICALS, INC. CEO Sell 36.3 -6,276 -0.53% $18.7K
Aug 18, 2025 Aug 20, 2025 ROCKET PHARMACEUTICALS, INC. CEO Sell 52.5 -2,234 -0.19% $6.8K
May 20, 2025 May 22, 2025 ROCKET PHARMACEUTICALS, INC. CEO Sell 51.3 -2,253 -0.19% $14.5K
May 16, 2025 May 20, 2025 ROCKET PHARMACEUTICALS, INC. CEO Sell 51.3 -3,621 -0.30% $23.6K
Apr 10, 2025 Apr 14, 2025 ROCKET PHARMACEUTICALS, INC. CEO Buy 82.5 +20,000 1.70% $101.6K
Feb 21, 2025 Feb 25, 2025 ROCKET PHARMACEUTICALS, INC. CEO Sell 42.5 -16,303 -1.36% $172.5K
Nov 21, 2024 Nov 25, 2024 ROCKET PHARMACEUTICALS, INC. CEO Sell 45.0 -11,091 -0.99% $144.8K
Aug 16, 2024 Aug 20, 2024 ROCKET PHARMACEUTICALS, INC. CEO Sell 45.0 -9,650 -0.85% $178.6K
May 14, 2024 May 20, 2024 ROCKET PHARMACEUTICALS, INC. CEO Sell 90.0 +81,935 7.79% $228.6K
Feb 16, 2024 Feb 21, 2024 ROCKET PHARMACEUTICALS, INC. CEO Sell 90.0 +46,305 4.72% $604.9K
Aug 17, 2023 Aug 21, 2023 ROCKET PHARMACEUTICALS, INC. CEO Sell 45.0 -4,767 -0.51% $73.8K
May 17, 2023 May 19, 2023 ROCKET PHARMACEUTICALS, INC. CEO Sell 47.5 -4,122 -0.44% $88.1K
Feb 17, 2023 Feb 22, 2023 ROCKET PHARMACEUTICALS, INC. CEO Sell 42.5 -12,194 -2.22% $232.4K
Feb 7, 2022 Feb 8, 2022 ROCKET PHARMACEUTICALS, INC. CEO Buy 85.0 +22,000 2.44% $381.5K
Mar 31, 2021 Apr 1, 2021 ROCKET PHARMACEUTICALS, INC. CEO Sell 32.5 -29,759 -3.19% $1.4M
Mar 30, 2021 Apr 1, 2021 ROCKET PHARMACEUTICALS, INC. CEO Sell 31.3 -173,241 -3.80% $7.6M
Mar 24, 2020 Mar 26, 2020 ROCKET PHARMACEUTICALS, INC. CEO Sell 40.0 -32,645 -3.07% $449.8K
Feb 25, 2020 Feb 27, 2020 ROCKET PHARMACEUTICALS, INC. CEO Sell 45.0 -6,233 -0.64% $125.6K
Mar 1, 2019 Mar 5, 2019 ROCKET PHARMACEUTICALS, INC. Officer Sell 23.8 -74,900 -9.83% $1.3M